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Background: The analysis of multiple causes of death data has been applied in the United States to examine the
population burden of chronic liver disease (CLD) and to assess time trends of alcohol-related and hepatitis C virus
(HCV)-related CLD mortality. The aim of this study was to assess the mortality for CLD by etiology in the Veneto
Region (northeastern Italy).
Methods: Using the 2008–2010 regional archive of mortality, all causes registered on death certificates were
extracted and different descriptive epidemiological measures were computed for HCV-related, alcohol-related, and
overall CLD-related mortality.
Results: The crude mortality rate of all CLD was close to 40 per 100,000 residents. In middle ages (35 to 74 years)
CLD was mentioned in about 10% and 6% of all deaths in males and females, respectively. Etiology was unspecified
in about half of CLD deaths. In females and males, respectively, HCV was mentioned in 44% and 21% and alcohol
in 11% and 26% of overall CLD deaths. A bimodal distribution with age was observed for HCV-related proportional
mortality among females, reflecting the available seroprevalence data.
Conclusions: Multiple causes of death analyses can provide useful insights into the burden of CLD mortality
according to etiology among different population subgroups.
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Mortality from liver cirrhosis has been declining in
southern Europe over the last decades, possibly due to a
reduction in alcoholic liver disease prevalence, a fall in
the transmission of hepatitis C virus (HCV) infection,
and vaccination campaigns against hepatitis B virus
(HBV) [1,2]. Nonetheless, in a recent European report,
the estimated HCV prevalence in the general Italian
population was as high as 5.2% for the whole country,
ranging from 2.4%-3.3% in northern regions to much
higher values in central and southern Italy [3]. Hepato-
cellular carcinoma mortality is very high in Italy with
respect to other European countries, with age standard-
ized rates -world standard- equal to 6.72 and 1.92 per* Correspondence: ugo.fedeli@regione.veneto.it
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reproduction in any medium, provided the or100,000 in males and females, respectively [3]. Overall,
about 60% of cirrhosis and hepatocellular carcinoma
deaths were estimated to be attributable to HCV at the
national level [3].
Usually mortality statistics are limited to the under-
lying cause of death, but a useful approach is repre-
sented by the analysis of all diseases reported on death
certificates (multiple cause of death analysis), because it
permits more extensive capture of chronic liver disease
(CLD)-related deaths. When liver cirrhosis is mentioned
on the death certificate, a related disease (e.g., liver can-
cer or viral hepatitis) or another disease category could
be selected as the underlying cause. Moreover, such ana-
lysis allows the retrieval of the etiology of CLD. Al-
though suffering from the underreporting of causes and
types of liver diseases, the analysis of multiple causes of
death data has been applied in US studies to examine
time trends in HCV- and alcohol-related CLD mortalitytd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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populations [8-10].
In the Veneto region (northeastern Italy) HCV sero-
prevalence is lower and alcohol consumption is higher
than the national average [11,12], and this could influ-
ence both the overall burden and the etiology of CLD.
The aim of this study was to examine the multiple
causes of death database from the Veneto region in
order to explore differences between analyses of the
underlying cause and of multiple causes of death, to as-
sess the most useful strategy in retrieving CLD-related
deaths, and to describe the regional burden of CLD mor-
tality according to etiology by gender, age class, and geo-
graphical area.
Methods
The Veneto region has about 4,900,000 inhabitants and
is subdivided into 21 local health units (LHUs) and 581
municipalities. Death certificates are sent by each muni-
cipality to the LHU, and the latter transmits a copy to
the regional epidemiological department for the coding
of causes of death according to the International Classi-
fication of Diseases, 10th Edition (ICD-10). Since 2008,
the electronic regional archive of mortality data is not
limited to the underlying cause of death, but includes all
diseases mentioned in the two parts of the death certifi-
cate. Part I includes conditions involved in the causal
chain of events leading to death, from the underlying
cause of death (e.g., liver cirrhosis) to the immediate
cause of death (e.g., cardiac arrest). Part II includes other
significant conditions that unfavorably influenced the
course of the morbid process and thus contributed to
the fatal outcome. Mortality statistics are based on
internationally-adopted selection and modification rules
that identify from all diseases reported on the death cer-
tificate a single underlying cause of death. The latter typ-
ically corresponds to the underlying cause stated in Part
I; however, it could be also another disease reported in
Part I or Part II or a derived condition [13]. In this study
we used the following terminology: underlying cause of
death for the disease selected according to international
rules for mortality statistics and CLD-related mortality
when the corresponding ICD-10 codes were retrieved
from any part of the death certificate.
To identify CLD-related deaths, any ICD-10 code for
conditions reported on the death certificate was selected
according to three strategies: Strategy 1 included codes usually adopted in liver
cirrhosis mortality statistics (K70, K73, K74).
 Strategy 2 added codes for chronic viral hepatitis,
portal hypertension, and unspecified liver disease
(B18, K76.6, and K76.9). Strategy 3 included all liver diseases and possible
complications such as liver cancer, icterus, ascites,
or esophageal varices (B15-B19, B94.2, I85.0, I98.2,
C22, K70-K76, R17, R18), as in a recent report from
Scotland [14].
Furthermore, ICD-10 codes were searched in the en-
tire death certificate to classify the disease as relating to
HBV (codes for acute or chronic infection: B16, B18.0,
B18.1), HCV (codes for acute or chronic infection:
B17.1, B18.2), or alcohol (codes for alcoholic liver dis-
eases and for mental and behavioral disorders due to the
use of alcohol: K70, F10).
To assess the most useful selection strategy, the total
number of included deaths, the crude mortality rate, the
proportion of deaths with identified etiology, and the
distribution of the underlying cause of death were exam-
ined. To explore differences between common mortality
statistics and multiple causes of death analysis, the num-
ber of deaths and crude rates were also computed by ap-
plying the three strategies of code selection only to the
underlying cause.
Descriptive epidemiological measures were calculated
for all CLD-related deaths and alcohol- and HCV-
related mortality resulting from the best selection
strategy. Crude and age-gender specific CLD-related
mortality rates were computed as number of deaths per
100,000 population, with population data derived from
the National Institute for Statistics (http://demo.istat.it/).
Age-standardized rates were calculated by the direct
standardization method according to different reference
populations (World, European, and US 2000 standard).
Lastly, in each gender and age class the proportional
mortality (percentage of all registered deaths) and the
share by etiology of total CLD-related deaths were
computed.
To assess the geographical variability of HCV- and
alcohol-related deaths, an indirect standardization method
was applied to compute the expected number of deaths in
each municipality based on regional rates. The observed
to expected ratio (standardized mortality ratio, SMR) for
each municipality was smoothed based on data from the
nearest municipalities according to a Gaussian kernel
function with a bandwidth equal to 10 kilometers [15],
and data were mapped by quintiles of smoothed SMR.
Results
Overall, 132,531 deaths were registered among residents
in the Veneto region in the period from 2008 to 2010.
Table 1 shows the results of different selection strat-
egies. If ICD-10 codes corresponding to strategy 1 were
searched only in the underlying cause of death (as in
usual liver cirrhosis mortality statistics), about 1.3% of
overall deaths were selected, with a crude rate slightly
Table 1 Number of deaths and crude mortality rates obtained with different selection criteria (ICD-10 codes) by
analysis of the underlying cause of death and of multiple causes of death; etiology of chronic liver diseases in the
multiple causes of death analysis
Selection 1 Selection 2 Selection 3
ICD-10 codes selected K70, K73, K74 B18, K70, K73, K74, K76.6, K76.9 B15-B19, B94.2, I85.0, I98.2, C22, K70-K76, R17, R18
Underlying cause of death analysis
Number of deaths 1694 2296 4141
Crude rate (× 105) 11.6 15.7 28.3
Multiple causes of death analysis
Number of deaths 4685 5941 9957
Crude rate (× 105) 32.0 40.6 68.1
Etiology, n (%):
Hepatitis C virus (B17.1, B18.2) 1000 (21%) 1756 (30%) 1763 (18%)
Hepatitis B virus (B16, B18.0, B18.1) 130 (3%) 258 (4%) 265 (3%)
Alcohol (F10, K70) 1215 (26%) 1221 (20%) 1233 (12%)
Other/not reported 2463 (53%) 2859 (48%) 6850 (69%)
Veneto region, 2008–2010.
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the multiple causes approach, even with the more re-
strictive strategy 1, at least 3.5% of total deaths could be
related to CLD, with a crude mortality rate above 30 per
100,000 residents. The main etiological factors listed on
death certificates were alcohol and HCV infection, with
a small proportion of deaths attributable to HBV. About
1.6% of death certificates reported the coexistence of al-
coholic liver disease and HCV (data not shown); about
half did not specify any etiology. When including chronic
viral hepatitis, portal hypertension, and unspecified liver
disease, the mortality rate increased to about 40 per
100,000 and the share attributable to HCV reached 30%.
If a broader spectrum of diseases possibly related to CLD
was selected, the number of identified deaths doubled,
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Figure 1 Multiple causes of death database, Veneto region, 2008–201
disease-related deaths retrieved by different identification strategies:
K76.6, K76.9), and Selection 3 (B15-B19, B94.2, I85.0, I98.2, C22, K70-KFigure 1 shows that with selection strategies 1 and 2,
viral hepatitis, liver cancer, and liver diseases were iden-
tified as the underlying cause of death in the majority of
CLD-related deaths; it is worth noting that at least 20%
of deaths had primary liver cancer identified as the
underlying cause. If a broader range of ICD-10 codes
was adopted (selection strategy 3), an underlying cause
not related to liver conditions was identified in more
than half of subjects; namely, deaths due to hepatic fail-
ure from liver metastases represented greater than 30%
of included cases. The second strategy reported in
Table 1 could therefore represent a compromise between
sensitivity and specificity of the selection, allowing for
the inclusion of all chronic viral hepatitis-related deaths
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0: underlying cause of death (ICD-10 codes) in chronic liver
Selection 1 (K70, K73, K74), Selection 2 (B18, K70, K73, K74,
76, R17, R18).
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measures for total CLD-related deaths and alcohol- and
HCV-related mortality according to selection strategy 2.
The few deaths with mention of both alcohol and HCV
were analyzed both among HCV- and alcohol-related
CLD. Overall, CLD represented almost 6% of all deaths
in males and greater than 3% in females, but amongTable 2 Age-specific number of deaths, mortality rates, propo
deaths, crude and age-standardized rates: all CLD, hepatitis C
and females of the Veneto region, 2008–2010
All CLD
Males Females
Crude rate (× 105) 51.3 30.3
US 2000 standard (× 105) 40.5 17.1
European standard (× 105) 37.1 14.3
World standard (× 105) 24.8 9.0
Number of deaths
<35 yrs 13 9
35-44 yrs 107 36
45-54 yrs 348 89
55-64 yrs 702 193
65-74 yrs 1161 434
≥75 yrs 1345 1504
all ages 3676 2265
Age-specific rates (× 105)
<35 yrs 0.5 0.3
35-44 yrs 8.3 2.9
45-54 yrs 32.5 8.5
55-64 yrs 80.5 21.5
65-74 yrs 165.5 54.2
≥75 yrs 274.4 169.4
% all deaths
<35 yrs 1.1% 1.6%
35-44 yrs 9.3% 5.4%
45-54 yrs 13.4% 5.9%
55-64 yrs 11.3% 6.0%
65-74 yrs 8.9% 6.1%
≥75 yrs 3.4% 2.7%








all agesthose aged 35 to 74 years this share was as high as 10%
and 6% in males and females, respectively. Age-
standardized rates showed that the burden of all CLD
and alcohol-related CLD was much higher in males, ex-
cept for HCV-related mortality, which was only slightly
higher than in females. Death rates reached high values
in the 45 to 54 year age class, but thereafter the increasertion over all deaths and chronic-liver disease (CLD)
virus (HCV)-related, and alcohol-related deaths, males
HCV-related Alcohol-related
Males Females Males Females
10.7 13.3 13.5 3.4
8.8 7.1 10.4 2.3
7.6 5.4 10.2 2.3
5.0 3.2 7.0 1.6
7 4 - -
47 18 34 10
106 21 104 34
88 25 249 63
181 148 328 74
336 775 252 73
765 991 967 254
0.3 0.2 - -
3.6 1.5 2.6 0.8
9.9 2.0 9.7 3.2
10.1 2.8 28.6 7.0
25.8 18.5 46.8 9.2
68.6 87.3 51.4 8.2
0.6% 0.7% - -
4.1% 2.7% 2.9% 1.5%
4.1% 1.4% 4.0% 2.2%
1.4% 0.8% 4.0% 2.0%
1.4% 2.1% 2.5% 1.0%
0.8% 1.4% 0.6% 0.1%
1.2% 1.4% 1.5% 0.4%
54% 44% - -
44% 50% 32% 28%
30% 24% 30% 38%
13% 13% 35% 33%
16% 34% 28% 17%
25% 52% 19% 5%
21% 44% 26% 11%
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to female ratio falling from 4:1 to 1.6:1 among elderly
subjects. This different pattern was mainly due to HCV-
related diseases: death rates were high in both genders
among subjects aged 45 to 54 years with a male to fe-
male ratio of 5:1, and further increased in subjects 65
years or older, especially among females, with a male to
female ratio falling below unity. In people aged 45 to 64
years, alcohol-related deaths represented a substantialHCV-related deaths
Alcohol-related deaths
Figure 2 Municipal data on hepatitis C virus (HCV)-related and alcoho
region, 2008–2010. Quintiles of smoothed standardized mortality ratios; 1
regional rates.proportion of all deaths (4% in males and 2% in females)
and of CLD deaths (about one-third in both genders); in
older age classes, they still accounted for a substantial
burden of mortality only in males, but not in females.
Figure 2 illustrates that among males the pattern of
CLD mortality at the municipal level was different
according to the etiology: there was an excess of
alcohol-related mortality in the northeastern part of the
region, whereas HCV-related mortality peaked in thel-related chronic liver disease deaths, males of the Veneto
00 = observed deaths equal to those expected according to
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ity displayed a pattern similar to that in males (data not
shown), whereas due to limited numbers no geographical
analysis of alcohol-related deaths was carried out.
Discussion
Analyses of multiple causes of death data demonstrated
that CLD led to a great burden of mortality in the Veneto
region, causing or contributing to about 10% of deaths
among males under 75. The contribution of alcohol and
HCV to overall CLD mortality was similar in men (about
20-25%) but not in women, where the proportion of
HCV-related deaths (44%) was four-fold higher than that
of alcohol-related CLD deaths (11%). Our finding that
about half of total CLD deaths were without specification
of etiology is similar to a figure reported in US data [10].
The multiple causes of death approach allowed a
much greater burden of mortality to be attributed to
CLD than usual statistics of liver cirrhosis deaths based
only on the underlying cause. This is due to the inclu-
sion of both a great number of deaths with primary liver
cancer as the underlying cause and of deaths with an
underlying cause listed in other disease categories. For
the latter group, a substantial role of CLD in the fatal
outcome could be questionable. However, it must be
remarked that due to aging of the population in the
Veneto region, about one-fourth of deaths in males and
half in females occur in very elderly people over 84; in
these subjects, it is often difficult to identify a single real
cause of death on clinical grounds, and the multiple
causes analysis could uncover the role of multiple
comorbidities in the fatal process.
Selection strategy 2 was chosen to examine the pat-
terns of CLD-related deaths by gender, age class, and
geographical area; however, the selection of codes could
be opportunely modulated based on the characteristics
of the database at hand. It is worth noting that with the
adopted strategy, hepatocellular carcinoma deaths with-
out mention of CLD were not included, and this could
lead to the problem of CLD-related mortality underesti-
mation even with the multiple causes of death approach.
Alcohol-related liver diseases could be particularly affected
by underreporting on death certificates because of the
stigma associated with alcohol abuse. However, alcohol-
related mortality rates found in the present study are similar
to the figures reported among non-Hispanics in data from
the US [10]. Furthermore, according to a survey carried out
in male Veneto workers in the early 2000s [12], alcohol con-
sumption was high in the areas with high alcohol-related
CLD mortality shown in Figure 2. The adopted list of
alcohol-related causes was somewhat restrictive; however, by
examining more ICD-10 codes of neurological, cardiac, and
other alcohol-related diseases, very few additional CLD
deaths could be related to alcohol (data not shown).In previous studies death certificates were linked to
medical or laboratory records, demonstrating that HCV
was mentioned in about two-thirds of death certificates of
subjects with HCV infection in studies from the US
[16,17] and in about half in one report from Scotland [14].
No validation of mortality data was carried out in the
present study. However, HCV-related mortality rates were
at least double of those reported in studies from the US
[4,7,10]; especially among females mortality rates were
more elevated than those registered in high-risk US sub-
populations such as Hispanics [10]. On the other hand,
the pattern of HCV-related proportional mortality, at least
in females, reflected the findings of a seroepidemiological
study recently carried out in Veneto, in which the distri-
bution of anti-HCV antibodies was bimodal, with peaks at
35–44 years (2.1%) and ≥75 years (12%) [11]. The high
peak in the elderly reflects a cohort effect of the epidemic
of HCV infection in Italy in the 1950s due to the wide-
spread use of nondisposable medical instruments. The
smaller peak in younger subjects may be related to intra-
venous drug abuse, tattooing, and piercing [11]. Such a
distribution shift towards the elderly cohorts could lead to
a decline in both HCV prevalence and HCV-related mor-
tality in the general population over the next decades.
However, these figures individuate also a relevant issue in
health care since clinicians are facing an increasing aging
population with HCV-related CLD [11]. Moreover, the
second smaller peak in the young and middle-aged classes
needs to be strictly monitored.
Although HBV-related mortality was of limited magni-
tude, ongoing immigration from high prevalence coun-
tries could lead to an increasing burden of disease and
deaths in the near future.
It is worth noting that in spite of the underreporting
of etiology, such patterns are consistent with the results
of prevalence studies in areas close to the Veneto region:
in a community in northern Italy where the prevalence
of CLD was ascertained by multiple data sources, HCV
was the main cause in both genders, closely followed by
alcohol abuse among males; about one out of four cases
had indefinite etiology [18].
Death certificates lack information on other etiological
factors such as nonalcoholic fatty liver disease (NAFLD)
and genetic, occupational, and environmental risk fac-
tors [10]. NAFLD represents a growing phenomenon,
and it is likely that it makes a significant contribution to
CLD mortality [1]. NAFLD is known to be particularly
prevalent in patients with diabetes [2], and in our re-
cords diabetes was reported in about 20% of CLD deaths
without mention of etiology.
To our knowledge, the present study is the first to
examine multiple causes of death for CLD outside the
US and UK. The present analyses depict different pat-
terns of alcohol-related and HCV-related CLD mortality
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to males among older age classes, alcohol-related mor-
tality emerges as a substantial issue in middle-aged sub-
jects of both genders, whereas HCV-related mortality
constitutes an important concern in younger subjects
and among the elderly.Conclusions
The multiple causes of death approach allowed to attri-
bute to CLD a much greater burden of mortality than
usual statistics of liver cirrhosis deaths based only on the
underlying cause, and could be potentially more useful for
the surveillance of CLD in the next years. To reduce
underreporting and improve epidemiological information
on the etiology of CLD, certifying physicians should be en-
couraged to fully compile death certificates. Bearing in
mind their inherent limits, such analyses should be
adopted whenever electronic archives with all the under-
lying and contributing causes of death are available.
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